Zoledronic acid for neonatal subcutaneous fat necrosis
Key Clinical Message
Subcutaneous fat necrosis (SFN) in infants producing severe hypercalcemia is a life‐threatening emergency. Pathophysiology may include enhanced gastrointestinal calcium absorption and bone resorption. We treated an infant with SFN and serum calcium of 15 mg/dL with prednisolone and low‐dose zoledronic acid. Serum calcium promptly normalized without rebound hypocalcemia, and redosing of zoledronic acid was not necessary.
Subcutaneous fat necrosis (SFN) in infants producing severe hypercalcemia is a life‐threatening emergency. Pathophysiology may include enhanced gastrointestinal calcium absorption and bone resorption. We treated an infant with SFN and serum calcium of 15 mg/dL with prednisolone and low‐dose zoledronic acid. Serum calcium promptly normalized without rebound hypocalcemia, and redosing of zoledronic acid was not necessary.
Source: Clinical Case Reports - Category: Journals (General) Authors: Jeremy A. Di Bari, Jennifer A. Nead, Scott J. Schurman Tags: Case Report Source Type: research
More News: Calcium | Emergency Medicine | Gastroenterology | General Medicine | Perinatology & Neonatology | Prednisolone | Reclast | Zometa